Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT3483 | Organism | Stachybotrys chartarum | Stachybotrys chartarum | IZ | = | 10 | mm | 19029325 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC473646 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
0.6978 | Remote Similarity | NPC313504 |
0.6573 | Remote Similarity | NPC313897 |
0.6225 | Remote Similarity | NPC238945 |
0.6182 | Remote Similarity | NPC185903 |
0.6182 | Remote Similarity | NPC286696 |
0.6131 | Remote Similarity | NPC174020 |
0.6092 | Remote Similarity | NPC60537 |
0.6 | Remote Similarity | NPC18223 |
0.6 | Remote Similarity | NPC327477 |
0.6 | Remote Similarity | NPC237812 |
0.5969 | Remote Similarity | NPC313514 |
0.5938 | Remote Similarity | NPC180462 |
0.5928 | Remote Similarity | NPC210947 |
0.5864 | Remote Similarity | NPC477118 |
0.5833 | Remote Similarity | NPC477120 |
0.5815 | Remote Similarity | NPC290959 |
0.5812 | Remote Similarity | NPC24589 |
0.5803 | Remote Similarity | NPC282458 |
0.5803 | Remote Similarity | NPC78941 |
0.5798 | Remote Similarity | NPC477119 |
0.5793 | Remote Similarity | NPC25465 |
0.5793 | Remote Similarity | NPC235501 |
0.5779 | Remote Similarity | NPC327613 |
0.5765 | Remote Similarity | NPC201900 |
0.574 | Remote Similarity | NPC470139 |
0.5714 | Remote Similarity | NPC15566 |
0.5689 | Remote Similarity | NPC126634 |
0.5655 | Remote Similarity | NPC470140 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC473646 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
0.6886 | Remote Similarity | NPD3697 | Discontinued |
0.6687 | Remote Similarity | NPD7842 | Phase 2 |
0.6554 | Remote Similarity | NPD3105 | Discontinued |
0.6402 | Remote Similarity | NPD1451 | Approved |
0.6386 | Remote Similarity | NPD8271 | Discontinued |
0.6265 | Remote Similarity | NPD5342 | Clinical (unspecified phase) |
0.625 | Remote Similarity | NPD5768 | Phase 2 |
0.6242 | Remote Similarity | NPD300 | Approved |
0.6159 | Remote Similarity | NPD1808 | Phase 1 |
0.6158 | Remote Similarity | NPD3130 | Discontinued |
0.6114 | Remote Similarity | NPD8641 | Approved |
0.6092 | Remote Similarity | NPD2180 | Approved |
0.6048 | Remote Similarity | NPD1431 | Approved |
0.6048 | Remote Similarity | NPD1430 | Approved |
0.6023 | Remote Similarity | NPD2604 | Approved |
0.602 | Remote Similarity | NPD8410 | Clinical (unspecified phase) |
0.6012 | Remote Similarity | NPD9183 | Clinical (unspecified phase) |
0.6 | Remote Similarity | NPD9133 | Approved |
0.6 | Remote Similarity | NPD8119 | Discontinued |
0.6 | Remote Similarity | NPD9628 | Approved |
0.5988 | Remote Similarity | NPD875 | Clinical (unspecified phase) |
0.5974 | Remote Similarity | NPD1368 | Approved |
0.5969 | Remote Similarity | NPD7138 | Phase 2 |
0.5943 | Remote Similarity | NPD1731 | Clinical (unspecified phase) |
0.5933 | Remote Similarity | NPD8105 | Discontinued |
0.5931 | Remote Similarity | NPD7465 | Suspended |
0.593 | Remote Similarity | NPD8629 | Discontinued |
0.5915 | Remote Similarity | NPD8075 | Discontinued |
0.5882 | Remote Similarity | NPD3706 | Clinical (unspecified phase) |
0.5872 | Remote Similarity | NPD7531 | Clinical (unspecified phase) |
0.5855 | Remote Similarity | NPD9412 | Discontinued |
0.5854 | Remote Similarity | NPD8261 | Discontinued |
0.5843 | Remote Similarity | NPD1120 | Approved |
0.5843 | Remote Similarity | NPD1121 | Approved |
0.5833 | Remote Similarity | NPD5683 | Clinical (unspecified phase) |
0.5833 | Remote Similarity | NPD7981 | Discontinued |
0.5833 | Remote Similarity | NPD5684 | Clinical (unspecified phase) |
0.5833 | Remote Similarity | NPD5682 | Phase 3 |
0.5784 | Remote Similarity | NPD7834 | Approved |
0.5756 | Remote Similarity | NPD9627 | Approved |
0.5724 | Remote Similarity | NPD613 | Phase 2 |
0.5682 | Remote Similarity | NPD3708 | Phase 2 |
0.5679 | Remote Similarity | NPD4812 | Phase 1 |
0.5667 | Remote Similarity | NPD2646 | Discontinued |
0.5635 | Remote Similarity | NPD8030 | Approved |
0.5629 | Remote Similarity | NPD9196 | Phase 2 |
0.5629 | Remote Similarity | NPD9345 | Clinical (unspecified phase) |
0.5628 | Remote Similarity | NPD8113 | Phase 2 |
0.5618 | Remote Similarity | NPD536 | Clinical (unspecified phase) |
0.5613 | Remote Similarity | NPD7980 | Clinical (unspecified phase) |
0.561 | Remote Similarity | NPD1356 | Approved |
0.561 | Remote Similarity | NPD1355 | Clinical (unspecified phase) |
0.561 | Remote Similarity | NPD1354 | Approved |
0.5608 | Remote Similarity | NPD3108 | Clinical (unspecified phase) |
0.5607 | Remote Similarity | NPD566 | Approved |
0.5607 | Remote Similarity | NPD568 | Approved |
0.5607 | Remote Similarity | NPD567 | Approved |
PubChem CID   | 44558933 |
ChEMBL   | CHEMBL448094 |
ZINC   |
Molecular Weight:   | 919.51 |
ALogP:   | -5.2625 |
MLogP:   | 3.55 |
XLogP:   | 2.243 |
# Rotatable Bonds:   | 40 |
Polar Surface Area:   | 391.5 |
# H-Bond Aceptor:   | 23 |
# H-Bond Donor:   | 13 |
# Rings:   | 2 |
# Heavy Atoms:   | 65 |